Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 10471-10475 [2020-03612]
Download as PDF
<![CDATA[
10471
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
classes, and applicants therefore, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If its application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a Bulk
Manufacturer of Marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a) as described
in 84 FR 44920, published on August
27, 2019.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on May 30, 2019, Irvine Labs, Inc., 1864
Swan Circle, Costa Mesa, California
92626–4739 applied to be registered as
a bulk manufacturer of the following
basic class of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled
substance
Marihuana Extract ..
Marihuana ...............
Tetrahydrocannabinols.
Drug code
7350
7360
7370
Schedule
I
I
I
The applicant noticed above applied
to become registered with DEA to grow
marihuana as bulk manufacturer
subsequent to a 2016 DEA policy
statement that provided information on
how it intended to expand the number
of registrations, and described in general
terms the way it would oversee those
additional growers. Before DEA
completes the evaluation and
registration process for applicants to
grow marihuana, DEA intends to
propose regulations in the near future
that would supersede the 2016 policy
statement and govern persons seeking to
become registered with DEA to grow
marihuana as bulk manufacturers,
consistent with applicable law, as
described in 84 FR 44920.
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
Gamma Hydroxybutyric
Acid.
lotter on DSKBCFDHB2PROD with NOTICES
Jkt 250001
2010
I
I
I
Dated: January 31, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–03617 Filed 2–21–20; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2020–03623 Filed 2–21–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–595]
[Docket No. DEA–585]
Bulk Manufacturer of Controlled
Substances Application: Patheon
Pharmaceuticals, Inc.
ACTION:
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
Notice of application.
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 24, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 23, 2019,
Patheon Pharmaceuticals, Inc., 2100 E
Galbraith Road, Cincinnati, Ohio
45237–1625 applied to be registered as
a bulk manufacturer of the following
basic class(es) of controlled substance:
SUPPLEMENTARY INFORMATION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 24, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on January 9, 2020,
Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664–8544 applied
to be registered as a bulk manufacturer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Drug
code
3-Fluoro-N-methylcathinone (3–FMC) .....................................................................................................................................
Cathinone ................................................................................................................................................................................
Methcathinone .........................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .....................................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .......................................................................................................................................
18:30 Feb 21, 2020
Schedule
The Gamma Hydroxbutyric Acid will
be produced during the process of
converting gamma-butyrolactone into a
new product for development. The
company plans to manufacture the
above-listed controlled substance as
Active Pharmaceutical Ingredient (API)
that will be further synthesized into
dosage forms of a new product. No other
activities for this drug code are
authorized for this registration.
Controlled substance
VerDate Sep<11>2014
Drug
code
Controlled substance
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
1233
1235
1237
1238
1246
1248
1249
Schedule
I
I
I
I
I
I
I
10472
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
Drug
code
lotter on DSKBCFDHB2PROD with NOTICES
Controlled substance
Naphyrone ...............................................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................................
Fenethylline .............................................................................................................................................................................
Aminorex ..................................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................................
Methaqualone ..........................................................................................................................................................................
Mecloqualone ..........................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..........................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....................
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............................
FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) .......................................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..............................
FUB–AMB, MMB-FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ...
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ...........................................................................
5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide .........................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ................
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ......................................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..............
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................................
5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .................................
5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ......................................
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..
MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ................
FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ......................................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..........................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..........................................................................................................
5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ............................
5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) .......................
4–CN–CUML–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .........................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...............................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) ................................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) ...............................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ..................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .........................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................................
4–MEAP (4-Methyl-alpha-ethylaminopentiophenone) .............................................................................................................
N-Ethylhexedrone ....................................................................................................................................................................
Alpha-ethyltryptamine ..............................................................................................................................................................
Ibogaine ...................................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ..................................................
Lysergic acid diethylamide ......................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ......................................................................................................
Marihuana Extract ...................................................................................................................................................................
Marihuana ................................................................................................................................................................................
Parahexyl .................................................................................................................................................................................
Mescaline .................................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ..................................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .....................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................................
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
Schedule
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7014
7019
7020
7021
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
7044
7047
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7297
7298
7315
7348
7350
7360
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
10473
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
Drug
code
lotter on DSKBCFDHB2PROD with NOTICES
Controlled substance
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................................
Bufotenine ................................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................................
Psilocybin .................................................................................................................................................................................
Psilocyn ...................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................................
4’-Chloro-alpha-pyrrolidinovalerophenone ...............................................................................................................................
MPHP, 4’-Methyl-alpha-pyrrolidinohexiophenone ...................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ......................................................................................................................................
N-Ethyl-3-piperidyl benzilate ....................................................................................................................................................
N-Methyl-3-piperidyl benzilate .................................................................................................................................................
N-Benzylpiperazine ..................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .............................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C–D) ...........................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C–E ) .............................................................................................................
2-(2,5-Dimethoxyphenyl)ethanamine (2C–H) ..........................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C–I) .................................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C–C) ...........................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C–N) .............................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C–P) ......................................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl)ethanamine (2C–T–4 ) ............................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B–NBOMe) .............................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C–NBOMe) .............................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I–NBOMe) ..................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................................
Butylone ...................................................................................................................................................................................
Pentylone .................................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .............................................................
a-PHP, alpha-Pyrrolidinohexanophenone ...............................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) ............................................................................................................
Acetyldihydrocodeine ...............................................................................................................................................................
Benzylmorphine .......................................................................................................................................................................
Codeine-N-oxide ......................................................................................................................................................................
Cyprenorphine .........................................................................................................................................................................
Desomorphine .........................................................................................................................................................................
Etorphine (except HCl) ............................................................................................................................................................
Codeine methylbromide ...........................................................................................................................................................
Dihydromorphine .....................................................................................................................................................................
Difenoxin ..................................................................................................................................................................................
Heroin ......................................................................................................................................................................................
Hydromorphinol .......................................................................................................................................................................
Methyldesorphine ....................................................................................................................................................................
Methyldihydromorphine ...........................................................................................................................................................
Morphine methylbromide .........................................................................................................................................................
Morphine methylsulfonate .......................................................................................................................................................
Morphine-N-oxide ....................................................................................................................................................................
Myrophine ................................................................................................................................................................................
Nicocodeine .............................................................................................................................................................................
Nicomorphine ...........................................................................................................................................................................
Normorphine ............................................................................................................................................................................
Pholcodine ...............................................................................................................................................................................
Thebacon .................................................................................................................................................................................
Acetorphine ..............................................................................................................................................................................
Drotebanol ...............................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ......................................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..........................................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ..........................................................................................................
Acetylmethadol ........................................................................................................................................................................
Allylprodine ..............................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..............................................................................................................
Alphameprodine .......................................................................................................................................................................
Alphamethadol .........................................................................................................................................................................
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7694
9051
9052
9053
9054
9055
9056
9070
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9560
9601
9602
9603
9604
9605
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
10474
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
Drug
code
lotter on DSKBCFDHB2PROD with NOTICES
Controlled substance
Benzethidine ............................................................................................................................................................................
Betacetylmethadol ...................................................................................................................................................................
Betameprodine ........................................................................................................................................................................
Betamethadol ...........................................................................................................................................................................
Betaprodine .............................................................................................................................................................................
Clonitazene ..............................................................................................................................................................................
Dextromoramide ......................................................................................................................................................................
Diampromide ...........................................................................................................................................................................
Diethylthiambutene ..................................................................................................................................................................
Dimenoxadol ............................................................................................................................................................................
Dimepheptanol .........................................................................................................................................................................
Dimethylthiambutene ...............................................................................................................................................................
Dioxaphetyl butyrate ................................................................................................................................................................
Dipipanone ...............................................................................................................................................................................
Ethylmethylthiambutene ..........................................................................................................................................................
Etonitazene ..............................................................................................................................................................................
Etoxeridine ...............................................................................................................................................................................
Furethidine ...............................................................................................................................................................................
Hydroxypethidine .....................................................................................................................................................................
Ketobemidone ..........................................................................................................................................................................
Levomoramide .........................................................................................................................................................................
Levophenacylmorphan ............................................................................................................................................................
Morpheridine ............................................................................................................................................................................
Noracymethadol .......................................................................................................................................................................
Norlevorphanol ........................................................................................................................................................................
Normethadone .........................................................................................................................................................................
Norpipanone ............................................................................................................................................................................
Phenadoxone ...........................................................................................................................................................................
Phenampromide ......................................................................................................................................................................
Phenoperidine ..........................................................................................................................................................................
Piritramide ................................................................................................................................................................................
Proheptazine ............................................................................................................................................................................
Properidine ..............................................................................................................................................................................
Racemoramide ........................................................................................................................................................................
Trimeperidine ...........................................................................................................................................................................
Phenomorphan ........................................................................................................................................................................
Propiram ..................................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..............................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ......................................................................................................................
Tilidine .....................................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................................
Para-Fluorofentanyl .................................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...............................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................................
Butyryl Fentanyl .......................................................................................................................................................................
Para-fluorobutyryl fentanyl .......................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .................................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .................................................................................................
Para-chloroisobutyryl fentanyl .................................................................................................................................................
Isobutyryl fentanyl ....................................................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................................
Thiofentanyl .............................................................................................................................................................................
Beta-hydroxythiofentanyl .........................................................................................................................................................
Para-methoxybutyryl fentanyl ..................................................................................................................................................
Para-methoxybutyryl fentanyl ..................................................................................................................................................
Valeryl fentanyl ........................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................................
Cyclopropyl Fentanyl ...............................................................................................................................................................
Cyclopentyl fentanyl ................................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .............................................................................................
Amphetamine ...........................................................................................................................................................................
Methamphetamine ...................................................................................................................................................................
Lisdexamfetamine ....................................................................................................................................................................
Phenmetrazine .........................................................................................................................................................................
Methylphenidate ......................................................................................................................................................................
Amobarbital ..............................................................................................................................................................................
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
9606
9607
9608
9609
9611
9612
9613
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
1631
1724
2125
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
10475
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
Drug
code
Controlled substance
Pentobarbital ............................................................................................................................................................................
Secobarbital .............................................................................................................................................................................
Glutethimide .............................................................................................................................................................................
Nabilone ...................................................................................................................................................................................
1-Phenylcyclohexylamine ........................................................................................................................................................
Phencyclidine ...........................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................................
Phenylacetone .........................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................................
Alphaprodine ............................................................................................................................................................................
Anileridine ................................................................................................................................................................................
Cocaine ....................................................................................................................................................................................
Codeine ...................................................................................................................................................................................
Etorphine HCl ..........................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................................
Oxycodone ...............................................................................................................................................................................
Hydromorphone .......................................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................................
Ecgonine ..................................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................................
Levomethorphan ......................................................................................................................................................................
Levorphanol .............................................................................................................................................................................
Isomethadone ..........................................................................................................................................................................
Meperidine ...............................................................................................................................................................................
Meperidine intermediate-A ......................................................................................................................................................
Meperidine intermediate-B ......................................................................................................................................................
Meperidine intermediate-C ......................................................................................................................................................
Metazocine ..............................................................................................................................................................................
Methadone ...............................................................................................................................................................................
Methadone intermediate ..........................................................................................................................................................
Metopon ...................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................................
Morphine ..................................................................................................................................................................................
Oripavine .................................................................................................................................................................................
Thebaine ..................................................................................................................................................................................
Dihydroetorphine .....................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................................
Oxymorphone ..........................................................................................................................................................................
Noroxymorphone .....................................................................................................................................................................
Phenazocine ............................................................................................................................................................................
Thiafentanil ..............................................................................................................................................................................
Piminodine ...............................................................................................................................................................................
Racemethorphan .....................................................................................................................................................................
Racemorphan ..........................................................................................................................................................................
Alfentanil ..................................................................................................................................................................................
Remifentanil .............................................................................................................................................................................
Sufentanil .................................................................................................................................................................................
Carfentanil ...............................................................................................................................................................................
Tapentadol ...............................................................................................................................................................................
Bezitramide ..............................................................................................................................................................................
Fentanyl ...................................................................................................................................................................................
Moramide-intermediate ............................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances in bulk for distribution to its
customers.
lotter on DSKBCFDHB2PROD with NOTICES
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–589]
[FR Doc. 2020–03612 Filed 2–21–20; 8:45 am]
ACTION:
Notice of application.
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
DATES:
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
or before March 25, 2020. Such persons
may also file a written request for a
hearing on the application on or before
March 25, 2020.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
ADDRESSES:
Importer of Controlled Substances
Application: PerkinElmer, Inc.
2270
2315
2550
7379
7460
7471
8333
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9260
9273
9300
9330
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10471-10475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03612]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-595]
Bulk Manufacturer of Controlled Substances Application: Chemtos,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 24, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on January 9, 2020, Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664-8544 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).... 1233 I
Cathinone............................. 1235 I
Methcathinone......................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC).... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC)..... 1249 I
[[Page 10472]]
Naphyrone............................. 1258 I
N-Ethylamphetamine.................... 1475 I
N,N-Dimethylamphetamine............... 1480 I
Fenethylline.......................... 1503 I
Aminorex.............................. 1585 I
4-Methylaminorex (cis isomer)......... 1590 I
Gamma Hydroxybutyric Acid............. 2010 I
Methaqualone.......................... 2565 I
Mecloqualone.......................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl- 7010 I
1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3- 7014 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2- 7021 I
(1-(4-fluorobenzyl)-1Hindazole-3-
carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone.
5F-AB-PINACA (N-(1-amino-3-methyl-1- 7025 I
oxobutan-2-yl)-1-(5-fluropentyl)-1H-
indazole-3-carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-
1H-indazole-3-carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-
1H-indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)- 7033 I
1H-indazole-3-carboxamido)-3-
methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5- 7036 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5- 7041 I
fluoropentyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4- 7047 I
FLUOROBENZYL) (N-(adamantan-1-yl)-1-
(4-fluorobenzyl)-1H-indazole-3-
carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.
5F-APINACA, 5F-AKB48 (N-(adamantan-1- 7049 I
yl)-1-(5-fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5- 7083 I
fluoropentyl)-N-(2-phenylpropan-2-yl)-
1H-indazole-3-carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N- 7085 I
(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-
b]pyridine-3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL- 7089 I
BUTINACA, 4-CN-CUMYL BINACA, CUMYL-
4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-
N-(2-phenylpropan-2-yl)-1H-indazole-3-
carboxamide).
SR-19 (Also known as RCS-4) (1-Pentyl- 7104 I
3-[(4-methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3- 7200 I
(1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl)indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
4-MEAP (4-Methyl-alpha- 7245 I
ethylaminopentiophenone).
N-Ethylhexedrone...................... 7246 I
Alpha-ethyltryptamine................. 7249 I
Ibogaine.............................. 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide............ 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Marihuana Extract..................... 7350 I
Marihuana............................. 7360 I
Parahexyl............................. 7374 I
Mescaline............................. 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine........... 7390 I
4-Bromo-2,5-dimethoxyamphetamine...... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine... 7392 I
4-Methyl-2,5-dimethoxyamphetamine..... 7395 I
2,5-Dimethoxyamphetamine.............. 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine...... 7399 I
3,4-Methylenedioxyamphetamine......... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
[[Page 10473]]
3,4-Methylenedioxy-N-ethylamphetamine. 7404 I
3,4-Methylenedioxymethamphetamine..... 7405 I
4-Methoxyamphetamine.................. 7411 I
5-Methoxy-N-N-dimethyltryptamine...... 7431 I
Alpha-methyltryptamine................ 7432 I
Bufotenine............................ 7433 I
Diethyltryptamine..................... 7434 I
Dimethyltryptamine.................... 7435 I
Psilocybin............................ 7437 I
Psilocyn.............................. 7438 I
5-Methoxy-N,N-diisopropyltryptamine... 7439 I
4'-Chloro-alpha- 7443 I
pyrrolidinovalerophenone.
MPHP, 4'-Methyl-alpha- 7446 I
pyrrolidinohexiophenone.
N-Ethyl-1-phenylcyclohexylamine....... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine..... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine. 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine 7473 I
N-Ethyl-3-piperidyl benzilate......... 7482 I
N-Methyl-3-piperidyl benzilate........ 7484 I
N-Benzylpiperazine.................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone 7498 I
(4-MePPP).
2-(2,5-Dimethoxy-4- 7508 I
methylphenyl)ethanamine (2C-D).
2-(2,5-Dimethoxy-4- 7509 I
ethylphenyl)ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl)ethanamine (2C- 7517 I
H).
2-(4-iodo-2,5- 7518 I
dimethoxyphenyl)ethanamine (2C-I).
2-(4-Chloro-2,5- 7519 I
dimethoxyphenyl)ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro- 7521 I
phenyl)ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl)ethanamine (2C-P).
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl)ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone). 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl)ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl)ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl)ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone.............................. 7541 I
Pentylone............................. 7542 I
N-Ethypentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-
pentan-1-one).
[alpha]-PHP, alpha- 7544 I
Pyrrolidinohexanophenone.
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone ([alpha]- 7546 I
PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl)indole).
Acetyldihydrocodeine.................. 9051 I
Benzylmorphine........................ 9052 I
Codeine-N-oxide....................... 9053 I
Cyprenorphine......................... 9054 I
Desomorphine.......................... 9055 I
Etorphine (except HCl)................ 9056 I
Codeine methylbromide................. 9070 I
Dihydromorphine....................... 9145 I
Difenoxin............................. 9168 I
Heroin................................ 9200 I
Hydromorphinol........................ 9301 I
Methyldesorphine...................... 9302 I
Methyldihydromorphine................. 9304 I
Morphine methylbromide................ 9305 I
Morphine methylsulfonate.............. 9306 I
Morphine-N-oxide...................... 9307 I
Myrophine............................. 9308 I
Nicocodeine........................... 9309 I
Nicomorphine.......................... 9312 I
Normorphine........................... 9313 I
Pholcodine............................ 9314 I
Thebacon.............................. 9315 I
Acetorphine........................... 9319 I
Drotebanol............................ 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzam
ide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol........................ 9601 I
Allylprodine.......................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine........................ 9604 I
Alphamethadol......................... 9605 I
[[Page 10474]]
Benzethidine.......................... 9606 I
Betacetylmethadol..................... 9607 I
Betameprodine......................... 9608 I
Betamethadol.......................... 9609 I
Betaprodine........................... 9611 I
Clonitazene........................... 9612 I
Dextromoramide........................ 9613 I
Diampromide........................... 9615 I
Diethylthiambutene.................... 9616 I
Dimenoxadol........................... 9617 I
Dimepheptanol......................... 9618 I
Dimethylthiambutene................... 9619 I
Dioxaphetyl butyrate.................. 9621 I
Dipipanone............................ 9622 I
Ethylmethylthiambutene................ 9623 I
Etonitazene........................... 9624 I
Etoxeridine........................... 9625 I
Furethidine........................... 9626 I
Hydroxypethidine...................... 9627 I
Ketobemidone.......................... 9628 I
Levomoramide.......................... 9629 I
Levophenacylmorphan................... 9631 I
Morpheridine.......................... 9632 I
Noracymethadol........................ 9633 I
Norlevorphanol........................ 9634 I
Normethadone.......................... 9635 I
Norpipanone........................... 9636 I
Phenadoxone........................... 9637 I
Phenampromide......................... 9638 I
Phenoperidine......................... 9641 I
Piritramide........................... 9642 I
Proheptazine.......................... 9643 I
Properidine........................... 9644 I
Racemoramide.......................... 9645 I
Trimeperidine......................... 9646 I
Phenomorphan.......................... 9647 I
Propiram.............................. 9649 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine.............................. 9750 I
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl................... 9812 I
3-Methylfentanyl...................... 9813 I
Alpha-methylfentanyl.................. 9814 I
Acetyl-alpha-methylfentanyl........... 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-yl)propionamide.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl...................... 9822 I
Para-fluorobutyryl fentanyl........... 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-
4-yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4- 9825 I
yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl........ 9826 I
Isobutyryl fentanyl................... 9827 I
Beta-hydroxyfentanyl.................. 9830 I
Beta-hydroxy-3-methylfentanyl......... 9831 I
Alpha-methylthiofentanyl.............. 9832 I
3-Methylthiofentanyl.................. 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl.......................... 9835 I
Beta-hydroxythiofentanyl.............. 9836 I
Para-methoxybutyryl fentanyl.......... 9837 I
Para-methoxybutyryl fentanyl.......... 9838 I
Valeryl fentanyl...................... 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Cyclopropyl Fentanyl.................. 9845 I
Cyclopentyl fentanyl.................. 9847 I
Fentanyl related-compounds as defined 9850 I
in 21 CFR 1308.11(h).
Amphetamine........................... 1100 II
Methamphetamine....................... 1105 II
Lisdexamfetamine...................... 1205 II
Phenmetrazine......................... 1631 II
Methylphenidate....................... 1724 II
Amobarbital........................... 2125 II
[[Page 10475]]
Pentobarbital......................... 2270 II
Secobarbital.......................... 2315 II
Glutethimide.......................... 2550 II
Nabilone.............................. 7379 II
1-Phenylcyclohexylamine............... 7460 II
Phencyclidine......................... 7471 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Phenylacetone......................... 8501 II
1-Piperidinocyclohexanecarbonitrile... 8603 II
Alphaprodine.......................... 9010 II
Anileridine........................... 9020 II
Cocaine............................... 9041 II
Codeine............................... 9050 II
Etorphine HCl......................... 9059 II
Dihydrocodeine........................ 9120 II
Oxycodone............................. 9143 II
Hydromorphone......................... 9150 II
Diphenoxylate......................... 9170 II
Ecgonine.............................. 9180 II
Ethylmorphine......................... 9190 II
Hydrocodone........................... 9193 II
Levomethorphan........................ 9210 II
Levorphanol........................... 9220 II
Isomethadone.......................... 9226 II
Meperidine............................ 9230 II
Meperidine intermediate-A............. 9232 II
Meperidine intermediate-B............. 9233 II
Meperidine intermediate-C............. 9234 II
Metazocine............................ 9240 II
Methadone............................. 9250 II
Methadone intermediate................ 9254 II
Metopon............................... 9260 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine.............................. 9300 II
Oripavine............................. 9330 II
Thebaine.............................. 9333 II
Dihydroetorphine...................... 9334 II
Levo-alphacetylmethadol............... 9648 II
Oxymorphone........................... 9652 II
Noroxymorphone........................ 9668 II
Phenazocine........................... 9715 II
Thiafentanil.......................... 9729 II
Piminodine............................ 9730 II
Racemethorphan........................ 9732 II
Racemorphan........................... 9733 II
Alfentanil............................ 9737 II
Remifentanil.......................... 9739 II
Sufentanil............................ 9740 II
Carfentanil........................... 9743 II
Tapentadol............................ 9780 II
Bezitramide........................... 9800 II
Fentanyl.............................. 9801 II
Moramide-intermediate................. 9802 II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances in bulk for distribution to its customers.
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03612 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P
